<DOC>
	<DOCNO>NCT01009619</DOCNO>
	<brief_summary>Preventive treatment azithromycin reduces prevalence fo Bronchiolitis Obliterans Syndrome lung transplantation .</brief_summary>
	<brief_title>Azithromycin Bronchiolitis Obliterans Syndrome</brief_title>
	<detailed_description>- Prospective , interventional , randomize , double-blind , placebo-controlled trial . - Clinical setting ( tertiary University Hospital ) . - Investigator-driven , pharmaceutical sponsor . - Lung transplant recipient . - Add-on study-drug ( placebo azithromycin ) 'standard care ' ( standardize , routine immunosuppressive infectious prophylactic protocol ) . - 1:1 inclusion ratio ( placebo : azithromycin ) . - Randomisation discharge informed consent .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Bronchiolitis</mesh_term>
	<mesh_term>Respiratory Tract Infections</mesh_term>
	<mesh_term>Bronchiolitis Obliterans</mesh_term>
	<mesh_term>Azithromycin</mesh_term>
	<criteria>Stable LTx recipient discharge transplantation . Signed informed consent Adult ( age least 18 year old moment transplantation ) Able take oral medication Prolonged and/or complicate ICUcourse transplantation . Early ( &lt; 30 day posttransplant ) postoperative death Major suture problem ( airway stenosis stent ) Retransplantation ( lung ) Previous transplantation ( solid organ ) Multiorgan transplantation ( lung+ solid organ )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2011</verification_date>
	<keyword>Bronchiolitis Obliterans Syndrome</keyword>
	<keyword>Acute allograft Rejection</keyword>
	<keyword>Lymphocytic bronchiolitis</keyword>
	<keyword>Respiratory infection</keyword>
	<keyword>Survival</keyword>
	<keyword>Mortality</keyword>
	<keyword>Pulmonary function</keyword>
	<keyword>FEV1</keyword>
	<keyword>Broncho-alveolar lavage</keyword>
	<keyword>Neutrophils</keyword>
	<keyword>Interleukin</keyword>
	<keyword>Culture</keyword>
	<keyword>Azithromycin</keyword>
</DOC>